Stay updated on Pembrolizumab Trastuzumab Combo in HER2+ Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Trastuzumab Combo in HER2+ Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Trastuzumab Combo in HER2+ Gastric Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision updated from v3.6.4 to v3.6.5, signaling a new build of the page. This reflects an internal version update rather than a content change.
    Difference
    0.1%
    Check dated 2026-08-08T18:20:31.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The page footer now shows the updated site revision number (v3.6.4), replacing the previous v3.6.3. This indicates a minor platform update that does not modify study content or functionality.
    Difference
    0.1%
    Check dated 2026-07-25T10:00:50.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    37 days ago
    Change Detected
    Summary
    Footer revision updated from v3.6.2 to v3.6.3, indicating a minor version update to the page rather than a content change.
    Difference
    0.1%
    Check dated 2026-07-03T21:50:18.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    Revision label on the page was updated from v3.6.0 to v3.6.2, indicating a small internal update to the page rendering or templates. No study content or user-visible information was altered.
    Difference
    0.1%
    Check dated 2026-06-27T00:21:43.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    New sections How to Read a Study Record, Common Questions, and How to Join a Study were added, and Hyun Cheol Chung and Yonsei University are now listed as the responsible party; the revision tag was updated from v3.5.5 to v3.6.0.
    Difference
    2%
    Check dated 2026-06-12T16:06:01.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    The page's footer revision label was updated from v3.5.4 to v3.5.5, indicating a new deployment or update to the site's interface. This appears to be a version-tracking or maintenance change rather than a modification to study details or content.
    Difference
    0.1%
    Check dated 2026-06-05T11:44:15.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Trastuzumab Combo in HER2+ Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Trastuzumab Combo in HER2+ Gastric Cancer Clinical Trial page.